Apricus Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Apricus Wealth's PFE Position: Q2 2026 in Review
Apricus Wealth reduced its Pfizer (PFE) stake by 91% in Q2 2026, selling an estimated $2.96M and leaving 11,154 shares worth $269K. The position accounts for 0.13% of the portfolio, ranked #108.
Apricus Wealth first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.49M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Apricus Wealth held 11,154 shares of Pfizer worth $269K as of Q2 2026.
- Apricus Wealth sold 113,108 Pfizer shares in Q2 2026, an estimated $2.96M.
- Pfizer made up 0.13% of Apricus Wealth's portfolio in Q2 2026, its #108 holding.
- Apricus Wealth first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Apricus Wealth's Pfizer position peaked at $3.49M in Q1 2026.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Apricus Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.